Taking stock of the drug industry, from the lab to the medicine chestMay 26, 2023Check out STAT+Sponsored ByBy Ed SilvermanPharmalot Columnist, Senior Writer Maria Fabrizio for STAT Science finally figured out how to make effective RSV vaccines. Will seniors care? There's a lack of appreciation of the impact RSV infections have on older adults, experts who research this virus acknowledge. By Helen Branswell STAT+ | U.K. unveils $800 million package to bolster life sciences amid concern over biopharma investments The new funding comes as biopharma companies raise alarms about policies they say are deterring them from investing further in the country. By Andrew Joseph STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman Adobe STAT+ | Opinion: An overlooked way to make participants in clinical trials look more like America About 30 million Americans, 59% of whom are members of racial and ethnic subgroups, receive care in a group of safety-net clinics. By Gloria Coronado and Leslie Bienen Some hoped a new oral vaccine would solve all the polio campaign's problems. Reality is settling in Experts say it has become clear that the polio vaccine is a safe and effective tool, but not a panacea that some expected. By Helen Branswell More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Pharmalot? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments